Not Signed In -
Schizophrenia |
Schizoid personality disorder; Schizotypal personality disorder |
Clinical Trial: A Long Term Study of Clozapine in Patients with Treatment-Resistant Schizophrenia
This study is no longer recruiting patients.
|
Purpose
Clozapine is an antipsychotic. This open study will evaluate the safety and efficacy of long term treatment of clozapine in patients with treatment-resistant schizophrenia.
| Condition | Intervention | Phase |
|---|---|---|
| Schizophrenia | Drug: Clozapine | Phase II |
MedlinePlus related topics: Schizophrenia
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study
Official Title: An Open Extension Study to Phase IIb Study of Clozapine in Patients with Treatment-Resistant Schizophrenia
Further Study Details:
Study start: January 2002
Clozapine is an antipsychotic. This open study will evaluate the safety and efficacy of long term treatment of clozapine in patients with treatment-resistant schizophrenia.
Eligibility
Ages Eligible for Study: 18 Years - 64 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Attended the previous Phase IIb (core) study
- Improved during the core study
- No safety issues during the core study
Exclusion Criteria:
- Discontinued the core study
- Pregnant or nursing (lactating) women
Other protocol-defined exclusion criteria may apply.
Location Information
Study chairs or principal investigators
Novartis Pharmaceuticals, Study Chair, Not applicable
More Information
Study ID Numbers: CLEX123J1202
Last Updated: September 9, 2005
Record first received: September 8, 2005
ClinicalTrials.gov Identifier: NCT00154258
Health Authority: Japan: Ministry of Health, Labor and Welfare
ClinicalTrials.gov processed this record on 2005-09-13
Last Updated: September 9, 2005
Record first received: September 8, 2005
ClinicalTrials.gov Identifier: NCT00154258
Health Authority: Japan: Ministry of Health, Labor and Welfare
ClinicalTrials.gov processed this record on 2005-09-13
Resources
- Ask NOAH About: Schizoaffective Disorder Fact Sheet (New York Online Access to Health, The New York Hospital Cornell Medical Center (NOAH))
- Ask NOAH About: Schizophrenia Fact Sheet (New York Online Access to Health, The New York Hospital Cornell Medical Center (NOAH))
email this page
print this page
bookmark this page
feedback on this page
